Treatment | Q E | A max [μmol m–2 s-1] | LCP | LSE |
---|---|---|---|---|
Control | 0.02 ± 0.00d1 | 10.33 ± 0.93c | 78.66 ±1.85a | 502.80 ±10.77a |
ABA | 0.04 ± 0.00c | 9.96 ± 0.85c | 52.96 ± 1.94b | 283.10 ± 9.56b |
High BR | 0.07 ± 0.00b | 13.26 ± 0.67bc | 52.28 ± 1.25b | 255.20 ± 8.74b |
ABA + low BR | 0.06 ± 0.00b | 13.88 ± 0.53bc | 54.21 ± 1.68b | 295.80 ± 10.65b |
ABA + medium BR | 0.07 ± 0.00b | 13.64 ± 0.78bc | 45.08 ± 1.34c | 548.40 ± 11.28a |
ABA + high BR | 0.11 ± 0.00a | 16.86 ± 0.91a | 25.07 ± 1.25d | 175.70 ± 10.34c |
High ABA + high BR | 0.11 ± 0.00a | 14.14 ± 0.94b | 24.58 ± 0.99d | 157.00 ± 10.26c |